Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic aminocyclitol glycoside and a member of the aminoglycoside class. It features a hexopyranose ring that is dideoxygenated at positions 4 and 6 and substituted at position 4 with an amino group linked to a cyclohexene moiety bearing multiple hydroxyl groups. The molecule has been described in chemical databases as an experimental small molecule but does not have any approved medical indications or known clinical use. Its mechanism of action is not well characterized; however it shares structural similarity with aminoglycosides that typically act by binding to bacterial ribosomal RNA and inhibiting protein synthesis[1][2][9]. No pharmacological or clinical data are available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose.